Skip to content

Homoeopathic treatment of depression in women after menopause

Adjunctive individualized homoeopathic medicines with cognitive behavioural therapy in improving post-menopausal depression: A double-blind, randomized, placebo-controlled trial

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050270
Enrollment
70
Registered
2023-03-02
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F329- Major depressive disorder, singleepisode, unspecified

Interventions

Intervention1: Individualized homeopathic medicines in centesimal potencies plus concomitant care (CBT): Intervention is planned as administering the indicated homeopathic medicines in centesimal pote
dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within

Sponsors

D N De Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Menopausal women with depression diagnosed as having the following - a) Typical Symptoms: Depressed mood, loss of interest and enjoyment, increased fatigability and diminished activity b) Common Symptoms: Reduced concentration and attention, reduced self-esteem and self-confidence, guilt feeling and unworthiness (mild type of episode), bleak and pessimistic view of the future, ideas or acts of self-harm or suicide, disturbed sleep, and diminished appetite 2. Age between 40 and 65 years 3. Woman, who has gone twelve months without menses 4. Mild and moderate depression [HDRS score: 8-13 mild, 14-18 moderate] 5. Literate patients: ability to read English, Hindi and Bengali. Illiterate patients will be interviewed by the investigators maintaining adequate privacy to fill up the scales or questionnaires. 6. Providing with written inform consent voluntarily

Exclusion criteria

Exclusion criteria: 1.No depression [HDRS Score: 0-7], or severe depression [HDRS score 18 or above] 2.Mood disturbance when associated with bipolar affective disorder, schizophrenia, schizophreniform disorder, schizoaffective disorder or psychotic disorder. 3.Currently receiving any effective anti-depressant. 4.Active suicidal thoughts. 5.Depression due to some organic disease or physiological effects of any medicine. 6.Hysterectomy and receiving any kind of hormone therapy. 7.Presence of medical conditions such as diabetes, hypertension, cardiac disorder & thyroid disorder. 8.Undergoing homoeopathic treatment for any chronic disease within last six months. 9.Vulnerable population - unconscious, non-ambulatory, too sick for consultation, differently abled, terminally ill or critically ill patients, institutionalized subjects, mentally incompetent people. 10.Self-reported immune-compromised state. 11.Patients with the habit of tobacco chewing and/or smoking, alcoholism and/or any other form(s) of substance abuse and/or dependence. 12.Simultaneous participation in any other clinical trials.

Design outcomes

Primary

MeasureTime frame
Hamiltonâ??s Depression Rating Scale (HDRS)Timepoint: At baseline, after 1 month and 2 months of intervention.

Secondary

MeasureTime frame
Menopause rating scale (MRS)Timepoint: At baseline, after 1 month and 2 months of intervention.;Montgomery-Asberg Depression Scale (MADRS):Timepoint: At baseline, after 1 month and 2 months of intervention.

Countries

India

Contacts

Public ContactDr Subhasish Ganguly

D N De Homoeopathic Medical College and Hospital,

dr.subhasish67@gmail.com9007263548

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026